Preparation and in-vivo evaluation of 99mTc-IOTIDA for cholescintigraphy

Applied Radiation and Isotopes

Volumn 61, Issue 6, 2004, Pages 1273-1278

  Hong, Young Don ^a   Jang, Beom Su ^a   Choi, Sang Mu ^a   Park, Woong Woo ^a   Park, Kyung Bae ^a   Choi, Sun Ju ^a  

^a Korea Atomic Energy Research Institute   (South Korea)

Author keywords

99mTc; Cholescintigraphy; Hepatobiliary imaging; IOTIDA

Indexed keywords

IMAGING TECHNIQUES; PHARMACOKINETICS; SCANNING;

CARBAMOYLMETHYL; RADIOLABELING; SCINTIGRAPHIC IMAGING;

RADIOISOTOPES;

3 IODO 2,4,6 TRIMETHYLPHENYLCARBAMOYLMETHYLIMINODIACETIC ACID TC 99M; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYSTIC DUCT; DIAGNOSTIC VALUE; DRUG ACCUMULATION; DRUG SCREENING; DRUG SYNTHESIS; GALLBLADDER; GALLBLADDER SCINTISCANNING; HEPATOBILIARY SYSTEM; IMAGING SYSTEM; LIVER FUNCTION; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; BILE DUCTS; DRUG EVALUATION, PRECLINICAL; GALLBLADDER; IMINO ACIDS; ISOTOPE LABELING; LIVER; MALE; METABOLIC CLEARANCE RATE; ORGAN SPECIFICITY; ORGANOTECHNETIUM COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; RABBITS; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY; TISSUE DISTRIBUTION;

EID: 4544261381     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2004.04.010     Document Type: Article

References (13)

1. Callery P.S., Faith W.C., et al. Tissue distribution of technetium-m and carbon-labelled N-(2,6)-dimetnylphenyl-carbamoylmethyl) iminodiacetic acid. J. Med. Chem. 19:1976;962-964
2. 99mTc-3-bromo-2,4,6-trimethyl-IDA in sequential hepatobiliary scintigraphy. J. Nucl. Med. Allied. Sci. 28:1984;167-179
3. 99mTc-diethyl Monoiodo-IDA. a radiopharmaceutical of hepatobiliary scintigraphy Appl. Radiat. Isot. 44:1993;843-848
4. 99mTc-labelled N-substituted carbamoylmethyl iminodiacetates. relationship between structure and biodistribution Int. J. Nucl. Med. Biol. 7:1980;1-7
5. Foster J.A., Ramsden W.H., Conway S.P., Taylor J.M., Etherington C. The role of IDA scintigraphy in the follow-up of liver disease in patients with cystic fibrosis. Nucl. Med. Commun. 23:2002;673-681
6. Johnson K., Alton H.M., Chapman S. Evaluation of mebrofenin hepatoscintigraphy in neonatal-onset jaundice. Pediatr. Radiol. 28:1998;937-941
7. 99mTc-HIDA SPECT. non-invasive measuring of intrahepatic bile flow. Description of the method and a study in primary sclerosing cholangitis Nucl. Med. Commun. 22:2001;127-134
8. 99mTc J. Labelled Compd. Radiopharm. 25:1988;1120-1197
9. Nowotnik, D.P., 1994. Physico-chemical concepts of technetium radiopharmaceuticals. In: Sampson, C.B. 2 (Eds.), Textbook of radiopharmacy. Gordon and Breach Science Publishers. Amsterdam, 41pp.
10. Nunn A.D., Loberg M.D., Conley R.A. A structure-distribution relationship approach leading to the development of Tc-99m mebrofenin. an improved choleschintigraphic agent J. Nucl. Med. 24:1983;423-430
11. 99mTc-diisopropyl-HIDA(DISIDA) in jaundicied patients Eur. J. Nucl. Med. 12:1986;346-350
12. 99mTc-labelled hepatobiliary radiopharmaceuticals Nucl. Med. Biol. 13:1986;509-514
13. Volkert A.W., Jurisson S. Technetium-99m chelates as radiopharmaceuticals. Yoshihara K., Omori T. Technetium and Rhenium: their chemistry and its applications. 1996;133-134 Springer, Berlin, Heidelberg